Disease Management Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Disease Management Market to 2025 - Global Analysis and Forecasts By Depolyments (On-Premise, Web-Based, Cloud-Based); Diseases (Cardiology, Respiratory, Oncology, Neuroloy and Others); End-Users (Payers, Providers, and Others); and Geography.

Report Code: TIPHE100001377 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Disease Management is generally relates to the concept of reducing healthcare cost that health to improvise the quality of life. The prevention is for an individual is done by preventing or minimizing the effects of chronic and acute diseases through integrated care. Disease management is a software and system of coordinates with the heath care interventions and communications for defined patient populations. The conditions are studied for self-care efforts can be implemented. Disease management enables an individual for working with other health care providers to manage disease and prevent complications.

The disease management market is expected to grow dramatically in the forecasted period. The key driving factors for growth of the market include the rise in the number of the patients suffering from chronic disease, rise in the geriatric population, uneven climatic conditions and more. Therefore, the advancement in the information technology is enabling patients to use the software, apps by themselves. This is creating opportunities for the developer to upgrade their software and solutions and services to grow themselves in the disease management market.

The "Global Disease Management Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global disease management market with detailed market segmentation by deployment, disease, end user and geography. The global disease management market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global disease management market is segmented on the basis of deployment, disease, and end user. On the basis of the deployment the segmentation includes on-premise, web-based and cloud based. The disease segment is classified as cardiology, respiratory, oncology, neurology, and others. On the basis of the end user the segment is classified as payer, provider, and others.

The disease management market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global disease management market based on deployment, disease, and end user. It also provides market size and forecast till 2025 for overall Disease management market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America holds the largest market share for the disease management market. Europe occupies the second largest market after the North American region for the disease management market. The market is anticipated to hold the largest market share in the forecasted period. The driving factors that are responsible for the driving factors are rise in the chronic diseases, rise in the number of people for their health conscious mentality, and advancement in the technology. The Asia Pacific is considered to be the fastest growing market due to the rise in the geriatric population, adoption of the healthcare facilities provided by the private and public entities and more.

The disease management market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The disease management market report also includes the profiles of disease management companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Avicenna Medical Systems, ScienceSoft USA Corporation., Avedon Health Systems, Orthus Health, West Health Advocate, Provata Health, U.S. Preventive Medicine, i2i Population Health, Pegasystems Inc., and ThoroughCare, Inc.
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. DISEASE MANAGEMENT MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Disease Management Market - By Deployment
3.2.2. Disease Management Market - By Disease
3.2.3. Disease Management Market - By End User
3.2.4. Disease Management Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. DISEASE MANAGEMENT MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. DISEASE MANAGEMENT MARKET - GLOBAL ANALYSIS
5.1. GLOBAL DISEASE MANAGEMENT MARKET OVERVIEW
5.2. GLOBAL DISEASE MANAGEMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS
6. DISEASE MANAGEMENT MARKET- GLOBAL REGULATORY SCENARIO
7. DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS TO 2025 - BY DEPOLYMENT
7.1. OVERVIEW
7.2. DEPOLYMENT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. ON-PREMISE MARKET
7.3.1. Overview
7.3.2. On-Premise Market Revenue Forecasts and Analysis (US$ Mn)
7.4. WEB-BASED MARKET
7.4.1. Overview
7.4.2. Web-Based Market Revenue Forecasts and Analysis (US$ Mn)
7.5. CLOUD-BASED MARKET
7.5.1. Overview
7.5.2. Cloud-Based Market Revenue Forecasts and Analysis (US$ Mn)
8. DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS TO 2025 - BY DISEASE
8.1. OVERVIEW
8.2. DISEASE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. CARDIOLOGY MARKET
8.3.1. Overview
8.3.2. Cardiology Market Revenue Forecasts and Analysis (US$ Mn)
8.4. RESPIRATORYMARKET
8.4.1. Overview
8.4.2. RespiratoryMarket Revenue Forecasts and Analysis (US$ Mn)
8.5. ONCOLOGY MARKET
8.5.1. Overview
8.5.2. Oncology Market Revenue Forecasts and Analysis (US$ Mn)
8.6. NEUROLOGY MARKET
8.6.1. Overview
8.6.2. Neurology Market Revenue Forecasts and Analysis (US$ Mn)
8.7. OTHERS MARKET
8.7.1. Overview
8.7.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
9. DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS TO 2025 - BY END USER
9.1. OVERVIEW
9.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3. PAYERS MARKET
9.3.1. Overview
9.3.2. Payers Market Revenue Forecasts and Analysis (US$ Mn)
9.4. PROVIDERS MARKET
9.4.1. Overview
9.4.2. Providers Market Revenue Forecasts and Analysis (US$ Mn)
9.5. OTHERS MARKET
9.5.1. Overview
9.5.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
10. NORTH AMERICA DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
10.1. NORTH AMERICA DISEASE MANAGEMENT MARKET OVERVIEW
10.2. NORTH AMERICA DISEASE MANAGEMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. NORTH AMERICA DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY DEPLOYMENT (US$ MN)
10.4. NORTH AMERICA DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
10.5. NORTH AMERICA DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.6. NORTH AMERICA DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.7. US MARKET OVERVIEW
10.7.1. US Disease Management Market Revenue Forecasts and Analysis - By Deployment (US$ Mn)
10.7.2. US Disease Management Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
10.7.3. US Disease Management Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. CANADA MARKET OVERVIEW
10.8.1. Canada Disease Management Market Revenue Forecasts and Analysis - By Deployment (US$ Mn)
10.8.2. Canada Disease Management Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
10.8.3. Canada Disease Management Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. MEXICO MARKET OVERVIEW
10.9.1. Mexico Disease Management Market Revenue Forecasts and Analysis - By Deployment (US$ Mn)
10.9.2. Mexico Disease Management Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
10.9.3. Mexico Disease Management Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11. EUROPE DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. EUROPE DISEASE MANAGEMENT MARKET OVERVIEW
11.2. EUROPE DISEASE MANAGEMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. EUROPE DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY DEPLOYMENT (US$ MN)
11.4. EUROPE DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
11.5. EUROPE DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.6. EUROPE DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.7. UK MARKET OVERVIEW
11.7.1. UK Disease Management Market Revenue Forecasts and Analysis - By Deployment (US$ Mn)
11.7.2. UK Disease Management Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
11.7.3. UK Disease Management Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. GERMANY MARKET OVERVIEW
11.8.1. Germany Disease Management Market Revenue Forecasts and Analysis - By Deployment (US$ Mn)
11.8.2. Germany Disease Management Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
11.8.3. Germany Disease Management Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.9. FRANCE MARKET OVERVIEW
11.9.1. France Disease Management Market Revenue Forecasts and Analysis - By Deployment (US$ Mn)
11.9.2. France Disease Management Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
11.9.3. France Disease Management Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. ASIA PACIFIC DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. ASIA PACIFIC DISEASE MANAGEMENT MARKET OVERVIEW
12.2. ASIA PACIFIC DISEASE MANAGEMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. ASIA PACIFIC DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY DEPLOYMENT (US$ MN)
12.4. ASIA PACIFIC DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
12.5. ASIA PACIFIC DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.6. ASIA PACIFIC DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.7. JAPAN MARKET OVERVIEW
12.7.1. Japan Disease Management Market Revenue Forecasts and Analysis - By Deployment (US$ Mn)
12.7.2. Japan Disease Management Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
12.7.3. Japan Disease Management Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. CHINA MARKET OVERVIEW
12.8.1. China Disease Management Market Revenue Forecasts and Analysis - By Deployment (US$ Mn)
12.8.2. China Disease Management Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
12.8.3. China Disease Management Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.9. INDIA MARKET OVERVIEW
12.9.1. India Disease Management Market Revenue Forecasts and Analysis - By Deployment (US$ Mn)
12.9.2. India Disease Management Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
12.9.3. India Disease Management Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. MIDDLE EAST AND AFRICA (MEA) DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
13.1. MIDDLE EAST AND AFRICA (MEA) DISEASE MANAGEMENT MARKET OVERVIEW
13.2. MIDDLE EAST AND AFRICA (MEA) DISEASE MANAGEMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. MIDDLE EAST AND AFRICA (MEA) DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY DEPLOYMENT (US$ MN)
13.4. MIDDLE EAST AND AFRICA (MEA) DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
13.5. MIDDLE EAST AND AFRICA (MEA) DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.6. MIDDLE EAST AND AFRICA (MEA) DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.7. SOUTH AFRICA MARKET OVERVIEW
13.7.1. South Africa Disease Management Market Revenue Forecasts and Analysis - By Deployment (US$ Mn)
13.7.2. South Africa Disease Management Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
13.7.3. South Africa Disease Management Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13.8. SAUDI ARABIA MARKET OVERVIEW
13.8.1. Saudi Arabia Disease Management Market Revenue Forecasts and Analysis - By Deployment (US$ Mn)
13.8.2. Saudi Arabia Disease Management Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
13.8.3. Saudi Arabia Disease Management Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13.9. UAE MARKET OVERVIEW
13.9.1. UAE Disease Management Market Revenue Forecasts and Analysis - By Deployment (US$ Mn)
13.9.2. UAE Disease Management Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
13.9.3. UAE Disease Management Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. SOUTH AND CENTRAL AMERICA DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
14.1. SOUTH AND CENTRAL AMERICA DISEASE MANAGEMENT MARKET OVERVIEW
14.2. SOUTH AND CENTRAL AMERICA DISEASE MANAGEMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
14.3. SOUTH AND CENTRAL AMERICA DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY DEPLOYMENT (US$ MN)
14.4. SOUTH AND CENTRAL AMERICA DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE (US$ MN)
14.5. SOUTH AND CENTRAL AMERICA DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
14.6. SOUTH AND CENTRAL AMERICA DISEASE MANAGEMENT MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
14.7. BRAZIL MARKET OVERVIEW
14.7.1. Brazil Disease Management Market Revenue Forecasts and Analysis - By Deployment (US$ Mn)
14.7.2. Brazil Disease Management Market Revenue Forecasts and Analysis - By Disease (US$ Mn)
14.7.3. Brazil Disease Management Market Revenue Forecasts and Analysis - By End User (US$ Mn)
15. INDUSTRY LANDSCAPE
15.1. ORGANIC GROWTH STRATEGIES
15.1.1. New Product Launches
15.1.2. Marketing & Promotional Activities
15.2. INORGANIC GROWTH STRATEGIES
15.2.1. Partnerships, Collaborations, and Joint Ventures
15.2.2. Mergers & Acquisitions
16. DISEASE MANAGEMENT MARKET, KEY COMPANY PROFILES
16.1. AVICENNA MEDICAL SYSTEMS
16.1.1. Key Facts
16.1.2. Business Description
16.1.3. Financial Overview
16.1.4. Product/Service Portfolio
16.1.5. SWOT Analysis
16.1.6. Key Developments
16.1.7. Company Clientele
16.2. SCIENCESOFT USA CORPORATION.
16.2.1. Key Facts
16.2.2. Business Description
16.2.3. Financial Overview
16.2.4. Product/Service Portfolio
16.2.5. SWOT Analysis
16.2.6. Key Developments
16.2.7. Company Clientele
16.3. AVEDON HEALTH SYSTEMS
16.3.1. Key Facts
16.3.2. Business Description
16.3.3. Financial Overview
16.3.4. Product/Service Portfolio
16.3.5. SWOT Analysis
16.3.6. Key Developments
16.3.7. Company Clientele
16.4. ORTHUS HEALTH
16.4.1. Key Facts
16.4.2. Business Description
16.4.3. Financial Overview
16.4.4. Product/Service Portfolio
16.4.5. SWOT Analysis
16.4.6. Key Developments
16.4.7. Company Clientele
16.5. WEST HEALTH ADVOCATE
16.5.1. Key Facts
16.5.2. Business Description
16.5.3. Financial Overview
16.5.4. Product/Service Portfolio
16.5.5. SWOT Analysis
16.5.6. Key Developments
16.5.7. Company Clientele
16.6. PROVATA HEALTH
16.6.1. Key Facts
16.6.2. Business Description
16.6.3. Financial Overview
16.6.4. Product/Service Portfolio
16.6.5. SWOT Analysis
16.6.6. Key Developments
16.6.7. Company Clientele
16.7. U.S. PREVENTIVE MEDICINE.
16.7.1. Key Facts
16.7.2. Business Description
16.7.3. Financial Overview
16.7.4. Product/Service Portfolio
16.7.5. SWOT Analysis
16.7.6. Key Developments
16.7.7. Company Clientele
16.8. I2I POPULATION HEALTH
16.8.1. Key Facts
16.8.2. Business Description
16.8.3. Financial Overview
16.8.4. Product/Service Portfolio
16.8.5. SWOT Analysis
16.8.6. Key Developments
16.8.7. Company Clientele
16.9. PEGASYSTEMS INC.
16.9.1. Key Facts
16.9.2. Business Description
16.9.3. Financial Overview
16.9.4. Product/Service Portfolio
16.9.5. SWOT Analysis
16.9.6. Key Developments
16.9.7. Company Clientele
16.10. THOROUGHCARE, INC.
16.10.1. Key Facts
16.10.2. Business Description
16.10.3. Financial Overview
16.10.4. Product/Service Portfolio
16.10.5. SWOT Analysis
16.10.6. Key Developments
16.10.7. Company Clientele
17. APPENDIX
17.1. ABOUT THE INSIGHT PARTNERS
17.2. GLOSSARY OF TERMS
17.3. RESEARCH METHODOLOGY
The List of Companies

1. Avicenna Medical Systems
2. ScienceSoft USA Corporation.
3. Avedon Health Systems
4. Orthus Health
5. West Health Advocate
6. Provata Health
7. U.S. Preventive Medicine.
8. i2i Population Health
9. Pegasystems Inc.
10. ThoroughCare, Inc.

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book